4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992260-26-000002
Options or other derivatives
- EVP, Head of R&D acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Randhawa Simrat EVP, Head of R&D | 2026-02-03 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X05/ownership.xml…